Gls-010, a novel anti-PD-1 mAb in Chinese patients with recurrent or metastatic cervical cancer: Results from a multicenter, open-label and single-arm phase II trial. This is an ASCO Meeting Abstract ...

Roche’s CINtec PLUS Cytology is the only FDA-approved and CE-marked dual-stain test to triage human papillomavirus (HPV)-positive cervical cancer screening test results Dual-stain biomarkers aid in ...

Cervical cancer has historically been a significant public health issue worldwide, causing substantial morbidity and mortality among women. Over recent decades, advances in screening, vaccination, and ...

TUCSON, Ariz., June 16, 2015 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced the publication of further results from the Primary ASC-US LSIL ...

Preoperative geriatric assessment (GA) and surgical outcomes in older women with gynecological (gyn) cancer. Validation of the predictive value of modeled HCG residual production “P” in low-risk ...

Please provide your email address to receive an email when new articles are posted on . HPV-based vs. cytology-based screening was tied to lower risks for invasive cervical cancer. Adverse events were ...

INDIANAPOLIS, March 11, 2024 /PRNewswire/ -- Roche Diagnostics today announced the release of new guidelines from ASCCP and other members of the Enduring Guidelines for Cervical Cancer Screening and ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The risk of ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Women ages 24 to ...